Previous close | 11.54 |
Open | 11.71 |
Bid | 10.98 x 100 |
Ask | 11.02 x 100 |
Day's range | 10.99 - 11.81 |
52-week range | 6.88 - 13.77 |
Volume | |
Avg. volume | 191,703 |
Market cap | 349.527M |
Beta (5Y monthly) | 0.45 |
PE ratio (TTM) | 47.83 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 05 Jan 2022 |
1y target est | N/A |
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the first quarter ended March 31, 2024.
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Tuesday, April 30, 2024 at 4:15 PM Eastern Time to discuss its financial results for the first quarter ended March 31, 2024. Financial results will be issued in a press release prior to the call.
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it is a recipient of the prestigious 2024 Top Workplaces USA award, featured in USA TODAY. This achievement underscores the organization's dedication to fostering a people-first workplace culture and prioritizing the employee experience.